One name that has started to get increasing attention on the OTC in recent action is Champignon Brands Inc (OTCMKTS:SHRMF). The story got more interesting last week when the company announced that it continues to augment its board of directors through “the appointment of accomplished business executives and thought leaders with successful track records of advancing research and awareness within the arena of depression, post-traumatic stress disorder, and substance abuse disorders”. To this accord, Champignon is pleased to appoint Dr. Bill Wilkerson, LL.D. (Hon) to its board of directors.
According to the release, an executive equipped with extensive service in business, government, broadcasting, the arts, and corporate crisis management, Dr. Wilkerson is an 8-time award-winning pioneer in workplace mental health. He led a Canadian-based, international initiative from 1998 to 2012 to recruit major employers in support of employee mental health, introducing the phrase and concept of mental health in the workplace. Dr. Wilkerson was previously President of one of Canada’s largest health benefits companies, Liberty Health, and held senior executive positions at the Royal Bank of Canada, CBC, and the Toronto Symphony Orchestra.
Champignon Brands Inc (OTCMKTS:SHRMF) promulgates itself as a company focused on the cultivation, distribution, and proliferation of medicinal mushrooms and their derivatives in North America.
It offers mushroom based tea products under the Vitality Supertea brand name, including Brain Enhance Supertea, a lions mane tropical green ginseng based tea product; Nourish Force Supertea, a reishi ryobus based tea product; Mighty Recharge Supertea, a cordycep and hibiscus blend with berries tea product; and wood tea box sets with 60 Supertea blends.
The company also sells mugs, shirts, and other tea-based accessories, as well as auralite healing stones. It sells its products through vitalitysuperteas.com Website, as well as third party coffee shops. The company was formerly known as Nature Leaf Wellness Corp. and changed its name to Champignon Brands Inc. in June 7, 2019.
Champignon Brands Inc. was founded in 2019 and is headquartered in Vancouver, Canada.
According to company materials, “Champignon Brands (CSE: SHRM) is focused on the formulation and manufacturing of novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. The Company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (PTSD), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the Company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified.”
Find out when $SHRMF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, SHRMF just announced that it has appointed Dr. Bill Wilkerson, LL.D. (Hon) to its board of directors.
Traders will note 18% added to share values of the company over the past month of action. What’s more, the company has seen a growing influx of trading interest, with the stock’s recent average trading volume running 18% beyond what we have been seeing over the larger time frame. This is particularly important with a float in play that’s limited — not even 20M shares.
“I am pleased to join the board of directors of Champignon to help deploy, at long last, treatments of depression that work, work fast, restore health, fuel hope, animate workplace productivity, and save lives,” said Dr. Wilkerson. “The mission of this company is fundamental and enduring; to meet a pressing public need. This is what my twenty-two years of advocacy for mental health in the workplace has been all about. This directorship also permits me to support and help facilitate the vision of the extraordinarily skilled and dedicated physician-scientist Dr. Roger McIntyre, a world leader in a field that cries out for his kind of resolve, courage, compassion, and knowledge. I am humbled by, and grateful for, the opportunity to serve.”
At this time, carrying a capital value in the market of $72M, SHRMF has virtually no cash on the books, which must be weighed relative to virtually no total current liabilities. The company is pre-revenue at this point. We will update the story again soon as developments transpire. Sign-up for continuing coverage on shares of $SHRMF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $SHRMF, either long or short, and we have not been compensated for this article.